InterCure Ltd.

Tel Aviv Stock Exchange INCR.TA

InterCure Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 125.34 M

InterCure Ltd. Shareholders' Equity is USD 125.34 M for the year ending December 31, 2023, a -12.01% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

InterCure Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 142.46 M, a -1.20% change year over year.
InterCure Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 144.19 M, a 68.88% change year over year.
InterCure Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 85.38 M, a 15.40% change year over year.
InterCure Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 73.99 M.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Tel Aviv Stock Exchange: INCR.TA

InterCure Ltd.

CEO	Mr. Alexander Rabinovich
IPO Date	Sept. 9, 2007
Location	Israel
Headquarters	85 Medinat ha-Yehudim Street
Employees	270
Sector	Consumers Staples
Industries Tobacco Alcoholic Beverages Biotechnology Bread & Bakery Cosmetics Personal Care Pharmaceuticals

Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Key trends

Past 5 years